Align Technology, Inc.

NasdaqGS:ALGN Lagerbericht

Marktkapitalisierung: US$12.1b

Align Technology Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Align Technology hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

2.5%

Rückkaufsrendite

Gesamte Aktionärsrendite2.5%
Zukünftige Dividendenrendite0%
Wachstum der Dividenden/a
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Ausschüttungsquoten/a

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Analyse-Update Apr 21

ALGN: Higher Fair Value Will Follow Renewed Bullish Rating And Governance Catalyst

The analyst fair value estimate for Align Technology moves to $240 from $225, with analysts pointing to recent Street research that reflects updated views on revenue growth, margins, and P/E assumptions following multiple price target raises and positive rating actions. Analyst Commentary Recent Street research on Align Technology has leaned more constructive, with several bullish analysts updating their views on the company and its valuation framework.
Analyse-Update Apr 07

ALGN: Post Conflict Recovery And Elliott Involvement Will Drive Bullish Repricing

The analyst price target for Align Technology holds at $200, as analysts point to an improved risk/reward skew after the recent pullback and highlight the company as well positioned once regional conflict pressures ease. Analyst Commentary Bullish analysts see the recent pullback as improving the setup for Align Technology, with the stock trading below its February levels after a 15% decline linked to Middle East conflict headlines.
Seeking Alpha Mar 24

Align Technology: Only International Growth Can Save Them Now (Downgrade)

Summary Align Technology (ALGN) is downgraded to a hold as recent share gains have priced in much of the near-term upside. ALGN faces stagnating revenue, declining margins, and potential market share erosion in clear aligners, especially in North America. International markets, particularly Latin America and APAC, offer double-digit volume growth potential, but North American saturation limits overall growth. Strong balance sheet, robust free cash flow, and ongoing buybacks provide stability, but lack of a clear path to double-digit growth tempers enthusiasm. Read the full article on Seeking Alpha
Analyse-Update Mar 23

ALGN: Post Conflict Demand Recovery And Elliott Engagement Will Shape Bullish Risk Reward

Align Technology's analyst fair value estimate has shifted modestly higher to about $201.69 from $198.67, as analysts point to an improved risk and reward setup following recent share weakness and a series of price target increases. These include a reiterated $200 target alongside an upgrade to Overweight at Barclays, as well as similar upward moves from several other firms.
Analyse-Update Mar 08

ALGN: Higher Fair Value Will Reflect Stronger Revenue And Margin Assumptions

The analyst fair value estimate for Align Technology has moved to $225 from $220, with the shift supported by recent price target increases across multiple firms and updated assumptions for revenue growth, profit margin, and a lower future P/E, partially offset by a higher discount rate. Analyst Commentary Recent Street research has centered on higher price targets and at least one fresh upgrade, which together align with the updated fair value estimate of US$225.
Analyse-Update Feb 22

ALGN: Margin Execution And P/E Expectations Will Shape Fairly Balanced Outlook

Align Technology's analyst price target has moved higher, with fair value estimates shifting from about $184 to roughly $199. Analysts are factoring in slightly stronger margin assumptions and a higher future P/E multiple, supported by a series of recent price target increases across major firms.
Analyse-Update Feb 08

ALGN: Future Multiple Compression Risk Will Test Execution Dependent Story

Analysts have lifted their price expectations for Align Technology, reflected in a higher implied fair value from about $140.00 to roughly $152.60, citing updated assumptions around revenue growth, profitability and future P/E multiples in recent research. Analyst Commentary Recent research activity around Align Technology has centered on revisiting fair value frameworks, with several firms adjusting price targets based on updated views of revenue potential, profitability and appropriate P/E multiples.
Analyse-Update Jan 25

ALGN: Q3 Volume Strength And Visibility Concerns Will Shape Balanced Outlook

Analysts have nudged their fair value estimate for Align Technology up by about $3 to $183.87, citing recent price target increases that reflect improved confidence in the company’s volume trends and revenue visibility following Q3 results. Analyst Commentary Recent research on Align Technology highlights a mix of optimism on execution following Q3 and ongoing caution around demand visibility and expectations for upcoming quarters.
Analyse-Update Jan 10

ALGN: Q3 Volume Strength And Cautious Outlook Will Shape Fairly Balanced Expectations

Narrative Update The analyst price target for Align Technology is now framed by a modestly higher intrinsic value estimate of about $180.47 per share, as analysts weigh recent target revisions around $200 and $170 against updated assumptions for growth, margins and future P/E. Analyst Commentary Recent Street commentary on Align Technology reflects a mix of renewed confidence in execution and ongoing caution around revenue visibility and the path to growth.
Analyseartikel Jan 04

Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analyse-Update Dec 21

ALGN: Q3 Volume Gains Will Support Renewed Confidence In Upcoming Revenue Ramp

Analysts have modestly raised their price target on Align Technology to $200 from $190, reflecting improved confidence in management's restored revenue visibility and Q4 execution following broad-based Q3 volume upside, even as valuation assumptions and long term growth forecasts remain largely unchanged. Analyst Commentary Recent Street commentary on Align Technology reflects a more constructive stance on near term execution, balanced by lingering questions around the durability of growth and visibility into 2025.
Analyse-Update Dec 07

ALGN: Q3 Volume Strength Will Support Confidence In Upcoming Revenue Ramp

Analysts have nudged their average price target on Align Technology modestly higher, by roughly $4 to about $184, as stronger than expected Q3 volume trends and improved visibility into hitting year end revenue goals outweighed lingering concerns about the pace of sequential improvement. Analyst Commentary Recent research updates reflect a generally constructive stance on Align Technology, with some lingering caution around execution into Q4 and beyond.
Analyse-Update Nov 23

ALGN: Recent Revenue Upside Will Improve Confidence In Forward Momentum

Analysts have raised their price target for Align Technology from $190 to $200 per share, citing improved revenue visibility and a stronger than expected third-quarter performance. Analyst Commentary Analysts have weighed in with both optimism and caution regarding Align Technology's outlook, highlighted by recent changes in price targets and ratings.
Analyse-Update Nov 08

ALGN: Volume Upside and Margin Strength Will Drive a Positive Outlook

Analysts have increased their price target for Align Technology from $175.07 to $180.50, citing improved revenue growth prospects, a stronger profit margin outlook, and management's recent success in delivering volume upside despite concerns about seasonality. Analyst Commentary Recent analyst updates on Align Technology reflect a range of perspectives, highlighting both positive developments and ongoing concerns in the company's outlook.
Analyse-Update Oct 24

Digital Workflow Improvements And Market Weakness Will Shape The Coming Year

Analysts have lowered their price target for Align Technology by approximately $5 to $175. They cite slightly softer revenue growth projections, modestly reduced profit margin expectations, and increased uncertainty around guidance for the upcoming quarters.
Analyse-Update Oct 10

Emerging Markets And Digital Workflow Will Fuel Future Success

Analysts have modestly lowered their price target for Align Technology, trimming it by approximately $6 to $180. Updated industry surveys and company results reflect both ongoing optimism and continued challenges in the dental market.
Analyseartikel Jul 17

Align Technology, Inc.'s (NASDAQ:ALGN) P/E Still Appears To Be Reasonable

With a price-to-earnings (or "P/E") ratio of 33.7x Align Technology, Inc. ( NASDAQ:ALGN ) may be sending very bearish...
Analyseartikel Jun 16

Returns On Capital At Align Technology (NASDAQ:ALGN) Have Stalled

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Analyseartikel Jun 01

Is Align Technology, Inc. (NASDAQ:ALGN) Potentially Undervalued?

Let's talk about the popular Align Technology, Inc. ( NASDAQ:ALGN ). The company's shares led the NASDAQGS gainers with...
Analyseartikel May 16

Investors Can Find Comfort In Align Technology's (NASDAQ:ALGN) Earnings Quality

Shareholders appeared unconcerned with Align Technology, Inc.'s ( NASDAQ:ALGN ) lackluster earnings report last week...
Analyseartikel May 14

Should Shareholders Reconsider Align Technology, Inc.'s (NASDAQ:ALGN) CEO Compensation Package?

Key Insights Align Technology's Annual General Meeting to take place on 21st of May Salary of US$1.40m is part of CEO...
Seeking Alpha Mar 07

Align Technology: Brace Yourself, This Stock Is Undervalued

Summary Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation. ALGN's market potential is strong, particularly with younger demographics, although recent revenue per shipment has softened. Read the full article on Seeking Alpha
Seeking Alpha Jan 05

Align Technology: Economic Headwinds Cloud An Attractive Growth Story

Summary Align Technology shares have remained under pressure over the past year due to soft consumer demand for the company’s clear aligner products. I expect growth to accelerate to at least 5% in FY25, mainly driven by strong demand for the systems and services that are sold to doctors. Profit margins are expected to improve, following the restructuring program initiated in Q4. Despite certain key risks, I find the valuation at 20.4 times FCF compelling enough to justify a Buy rating for this dominant player in the industry. Read the full article on Seeking Alpha
Seeking Alpha Oct 27

Align Technology: A Change In Plans After Mixed Q3 Earnings

Summary Align Technology reported mixed Q3 earnings, with a beat on EPS at $2.35 but a slight miss on revenue at $977.87M. Despite challenges in the U.S. market, growth in Asia Pacific, EMEA, and Latin America, and increased Clear Aligner volume, show resilience. Align's growth drivers include product enhancements, infrastructure investments, and partnerships, with expected revenue growth of 5.29%-7.53% year-over-year from Q4 2024 to Q4 2026. Risks include premium valuation, economic factors affecting consumer spending, and foreign exchange fluctuations, but I plan to add to my position at attractive price levels. Read the full article on Seeking Alpha

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von ALGN in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von ALGN gestiegen sind.


Dividendenrendite im Vergleich zum Markt

Align Technology Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von ALGN im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (ALGN)n/a
Untere 25 % des Marktes (US)1.4%
Markt Top 25 % (US)4.2%
Branchendurchschnitt (Medical Equipment)2.3%
Analystenprognose (ALGN) (bis zu 3 Jahre)0%

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von ALGN im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von ALGN im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von ALGN, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da ALGN keine Ausschüttungen gemeldet hat.


Entdecken Sie dividendenstarke Unternehmen

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/11 01:42
Aktienkurs zum Tagesende2026/05/11 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Align Technology, Inc. wird von 43 Analysten beobachtet. 15 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Jeffrey JohnsonBaird
Glen SantangeloBarclays
Charley JonesBarrington Research Associates, Inc.